Skip to main content
SpringerLink
Log in
Book cover

The Opioid Epidemic and the Therapeutic Community Model pp 63–74Cite as

Response to the Opioid Epidemic: Current Treatment Models in the United States

  • Chapter
  • First Online:

  • 515 Accesses

Abstract

Opioid use disorder (OUD) is a complex condition requiring a multifaceted treatment approach. As such, a variety of different models, both pharmacologic and non-pharmacologic, have been proposed and ultimately implemented as part of standard clinical practice over the past several decades, each providing a specific focus and expected therapeutic outcome. This chapter will take a closer look at such clinical approaches in their respective historical contexts, highlighting both their similarities and differences, while emphasizing the ongoing evolution of clinical approaches to an alarming and ever-changing public health crisis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Avery J, Barnhill J. Co-occurring mental illness and substance use disorders: a guide to diagnosis and treatment. Arlington: American Psychiatric Publishing; 2017.

    Google Scholar 

  2. Center for Behavioral Health Statistics and Quality. Key substance use and mental health indicators in the United States: results from the 2015 national survey on drug use and health. NoSMA 16-4984, NSDUH Ser H-51. 2016;7(1):877–726.

    Google Scholar 

  3. Friedman PD, McCullough D, Saitz R. Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists. Arch Intern Med. 2001;161:248–51.

    Article  Google Scholar 

  4. Finney JW, Moos RH, Wilbourne PL. Effects of treatment setting, duration, and amount on patient outcomes. In: Ries RK, Miller SC, Saitz R, Fiellin DA, editors. American Society of Addiction Medicine The ASAM principles of addiction medicine. 5th ed. Philadelphia: Wolters Kluwer Health and Lippincott Williams & Wilkins; 2014.

    Google Scholar 

  5. Galanter M, Kleber HD. The American psychiatric publishing textbook of substance abuse treatment. 4th ed. Washington D.C: American Psychiatric Publishing; 2008.

    Book  Google Scholar 

  6. Geller G, Levine DM, Mamon JA, et al. Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism. JAMA. 1989;262(21):3115–20.

    Article  Google Scholar 

  7. Gryczynski J, Schwartz RP, O’Grady KE, et al. Understanding patterns of high-cost health care use across different substance user groups. Health Aff (Millwood). 2016;35(1):12–9.

    Article  Google Scholar 

  8. Herron AJ, Brennan TK. The ASAM essentials of addiction medicine. 2nd ed. Philadelphia: Wolters Kluwer; 2015.

    Google Scholar 

  9. Humphreys K. Avoiding globalisation of the prescription opioid epidemic. Lancet. 2017;390:437–9.

    Article  Google Scholar 

  10. Ianucci R, Sanders K, Greenfield S. A 4-year curriculum on substance use disorders for psychiatry residents. Acad Psychiatry. 2009;33(1):60–6.

    Article  Google Scholar 

  11. Koob GF, Vokow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;35:217–38.

    Article  Google Scholar 

  12. Miller NS, Sheppard LM, Colenda CC, et al. Why physicians are unprepared to treat patients who have alcohol- and drug-related disorders. Acad Med. 2001;76:410–8.

    Article  Google Scholar 

  13. Polydorou S, Gunderson EW, Levin FR. Training physicians to treat substance use disorders. Curr Psychiatry Rep. 2008;10(5):399–404.

    Article  Google Scholar 

  14. Renner JA, Levounis P, LaRose AT. Office-based Buprenorphine treatment of opioid use disorder. 2nd ed. Arlington: American Psychiatric Association Publishing; 2018.

    Google Scholar 

  15. Ruiz P, Strain S. Substance abuse: a comprehensive textbook. 5th ed. Philadelphia: Wolters-Kluwer; 2011.

    Google Scholar 

  16. Samet JH, Friedmann P, Saitz R. Benefits of linking primary medical care and substance abuse services: patient, provider, and society perspectives. Arch Intern Med. 2001;161(1):85–91.

    Article  Google Scholar 

  17. Van Boekel LC, Brouwers EPM, Van Weeghel J, et al. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–3):23–35.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY, USA

    Joseph Bravoco

Authors
  1. Joseph Bravoco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph Bravoco .

Editor information

Editors and Affiliations

  1. Weill Cornell Medical College, New York, NY, USA

    Jonathan D. Avery

  2. Payne Whitney Clinic of New York-Presbyterian, Weill Cornell Medical College, New York, NY, USA

    Kristopher A. Kast

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bravoco, J. (2019). Response to the Opioid Epidemic: Current Treatment Models in the United States. In: Avery, J., Kast, K. (eds) The Opioid Epidemic and the Therapeutic Community Model. Springer, Cham. https://doi.org/10.1007/978-3-030-26273-0_5

Download citation

Publish with us

Policies and ethics

Search

Navigation